Partners Group Exits and Reinvests in PCI Pharma Services
Deal News | Jul 14, 2025 | Ropes & Gray
In a notable transaction, Ropes & Gray provided legal advisory services to Partners Group in its strategic exit and reinvestment in PCI Pharma Services. Partners Group, a leading player in the global private markets industry with over 1,800 professionals and more than $150 billion in assets under management, decided to exit its initial investment in PCI Pharma, a prominent contract development and manufacturing organization specializing in biotherapies. Subsequently, they reinvested in the company as part of a consortium led by Bain Capital and Kohlberg & Company, which acquired a majority share in PCI Pharma. This deal was publicized on July 14, and the advisory team from Ropes & Gray was led by private equity partners Gabrielle DiBernardi and Bob Rivollier, and included experts from asset management, tax, life sciences, and healthcare.
Sectors
- Private Equity
- Pharmaceuticals & Biotechnology
- Legal Advisory
Geography
- Global – The global scope is highlighted by the involvement of international firms like Partners Group, Bain Capital, and PCI Pharma Services.
Industry
- Private Equity – This industry is relevant as the article discusses Partners Group, a major player in the private equity market, and their strategic investment decisions.
- Pharmaceuticals & Biotechnology – PCI Pharma Services operates in this industry, focusing on contract development and manufacturing of biotherapies.
- Legal Advisory – Ropes & Gray's involvement as legal advisors showcases the role of legal firms in facilitating complex transactions in this industry.
Financials
- $150 billion – Partners Group's assets under management.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Partners Group | Investor | Company | A leading global private markets investment management firm with over $150 billion in assets under management. |
| PCI Pharma Services | Target Company | Company | A world-leading global contract development and manufacturing organization focused on innovative biotherapies. |
| Bain Capital | Bidding Company | Company | A leading global private investment firm part of the consortium acquiring a majority stake in PCI Pharma Services. |
| Kohlberg & Company | Bidding Company | Company | Part of the consortium alongside Bain Capital acquiring a majority interest in PCI Pharma Services. |
| Ropes & Gray | Legal Advisor | Company | The law firm advising Partners Group on the exit and reinvestment in PCI Pharma Services. |
| Gabrielle DiBernardi | Private Equity Partner | Person | Led the Ropes & Gray deal team advising Partners Group. |
| Bob Rivollier | Private Equity Partner | Person | Co-led the Ropes & Gray deal team. |